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Abstract The ability of ethanol to inhibit regenerative processes
in the liver is thought to play a key role in the development of
alcoholic liver disease. To understand the underlying mechan-
isms, we investigated the effects of ethanol on the Janus kinase-
signal transducer and activator transcription factor (JAK-
STAT) signaling pathways in hepatocytes. Treatment of freshly
isolated adult rat hepatocytes with 10^100 mM ethanol rapidly
(6 3 min) inhibits interleukin-6 (IL-6)-induced STAT3 activa-
tion, tyrosine and serine phosphorylation and IL-6-induced
CCAAT enhancer binding protein (C/EBP) K and L mRNA
expression. Western analyses, in vitro kinase assays and in vivo
cell labelling assays indicate that this inhibitory effect is not due
to blocking the upstream-located JAK1, JAK2 or Tyk2
activation. On the contrary, acute ethanol exposure significantly
potentiates IL-6-induced JAK1 autophosphorylation in vitro and
in vivo. Pretreatment with sodium vanadate, a non-selective
tyrosine phosphatase inhibitor, or with MG132 and lactacystin,
proteasome inhibitors, does not abolish the ethanol inhibition of
IL-6-induced STAT3 activation, suggesting that activation of
protein tyrosine phosphatases or the ubiquitin-proteasome path-
way is not involved. In view of the critical role of IL-6 signaling
in liver regeneration, these findings suggest that the ability of
biologically relevant concentrations of ethanol to markedly
inhibit IL-6-induced STAT3 phosphorylation is one of the
cellular mechanisms involved in the pathogenesis and progression
of alcoholic liver diseases.
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1. Introduction
The Janus kinase-signal transducer and activator transcrip-
tion factor (JAK-STAT) signaling pathways were originally
identi¢ed in the study of interferon signaling and are now
believed to be the major pathways involved in signal trans-
duction for many cytokines and growth factors. These path-
ways have been implicated in a variety of cellular functions in
the hematopoietic, immunologic, neuronal and hepatic sys-
tems [1^6]. In the liver, JAK-STAT activated by interleukin-6
(IL-6) has been shown to play a critical role in hepatic regen-
eration and in the acute phase response [7^9]. It is well-estab-
lished that the binding of IL-6 to the IL-6 receptor K chain
induces homodimerization of the signal transducing L chain
gp130, which is followed by activation of the receptor-associ-
ated tyrosine kinases, known as JAK1, JAK2 and Tyk2. This
receptor-kinase complex interacts with and activates the SRC
homology 2 (SH2)-containing cytoplasmic STAT3 transcrip-
tion factor, which then translocates to the nucleus to activate
the transcription of many target genes, such as c-jun, c-myc,
Jun B, CCAAT enhancer binding protein (C/EBP),
p21WAF1=Cip1 [1^3,8,10].
It is well known that excessive ethanol consumption dam-
ages the liver and it is also well-established that the ability of
ethanol to inhibit liver regeneration is a major factor in etha-
nol-induced liver damage [11^16]. We have previously shown
that in vitro treatment of freshly isolated hepatocytes with
biologically relevant concentrations of ethanol (50^100 mM)
signi¢cantly inhibits IL-6-induced STAT3 activation [17]. In
the present study, we demonstrate that ethanol inhibition of
IL-6-induced STAT3 activation develops rapidly, is most
likely due to inhibition of tyrosine and serine phosphorylation
of STAT3 and it results in a suppression of IL-6-induced C/
EBPK and C/EBPL mRNA expression. The data further in-
dicate that the ethanol inhibition on IL-6-induced STAT3
phosphorylation is not due to inhibition of JAK1, JAK2 or
Tyk2 phosphorylation or due to activation of a tyrosine phos-
phatase.
2. Materials and methods
2.1. Materials
STAT3, JAK1, JAK2, Tyk2, anti-phosphotyrosine antibodies were
purchased from Upstate Biotechnology (Lake Placid, NY, USA).
Anti-phospho-STAT3 (Tyr705) and anti-phospho-STAT3 (Ser727) anti-
bodies were from Bio-lab (Beverly, MA, USA). The following re-
agents were obtained from Sigma Chemicals (St. Louis, MO, USA):
ethanol, collagenase type IV, sodium vanadate and Nonidet P-40. GF
109203X, MG132 and lactacystin were from Calbiochem (San Diego,
CA, USA). IL-6 was a gift from Dr Tian Zhigang (Shandong Acad-
emy of Medical Sciences). Radiolabelled [Q-32P]ATP and carrier-free
[32P]phosphate were from Dupont NEN (Boston, MA, USA).
2.2. Isolation of hepatocytes
Liver cells were isolated by a collagenase perfusion protocol as
described earlier [17]. The isolated cells were washed twice and resus-
pended in Krebs-Henseleit solution (118 mM NaCl, 4.7 mM KCl,
1.2 mM MgSO4, 2.5 mM CaCl2, 1.2 mM KH2PO4, 25 mM NaHCO3
and 10 mM glucose) containing 1.5% gelatin and were further treated
with ethanol or IL-6.
2.3. DNA gel mobility shift assay (DMSA)
The DMSA was described previously [18]. The STAT3 binding site
of oligo m67 (the high a⁄nity serum-induced element m67) (5P-GTC
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GAC ATT TCC CGT AAA TCG TCG A-3P) [19,20] was used as a
probe.
2.4. Northern blotting analyses
Northern analyses were done as described previously [21]. Brie£y,
total cellular RNA was extracted and puri¢ed by the guanidinium
isothiocyanate method, using the RNAzol B kit (Cinna/Biotecx).
The RNA was electrophoretically fractionated on a 1.0% agarose
gel containing 6.5% formaldehyde and transferred onto a nylon mem-
brane. The size of the bands was estimated by comparison with the
migration of a 0.24^9.5 kb RNA ladder (Gibco). Blots were pre-hy-
bridized for 2 h in a bu¡er containing 50% formamide, 5UDenhardt’s
solution, 100 Wg/ml sheared salmon sperm DNA and 0.5% SDS. Hy-
bridization was carried out at 42‡C overnight in the above solution,
using 32P-labelled C/EBPK or C/EBPL cDNA probes. Blots were
washed in 1USSC, 0.1% SDS for 20 min at room temperature fol-
lowed by two washes of 20 min each in 0.2USSC, 0.1% SDS at 65‡C.
Bands were visualized and quanti¢ed by phosphorimaging, using a
phosphorimager and the ImageQuant program (Molecular Dynam-
ics).
2.5. Reverse transcriptase-polymerase chain reaction (RT-PCR)
The RT-PCR was described previously [18]. The following primer
pairs were used: forward primer (5P-GAA TCT CCT AGT CCT
GGC TC-3P) and reverse primer (5P-GAT GAG AAC AGC AAC
GAG TAC-3P) for rat C/EBPK ; forward primer (5P-GCC ACG
GAC ACC TTC GAG G-3P) and reverse primer (5P-CGG CTC
CGC CTT GAG CTG-3P) for rat C/EBPL ; forward primer (5P-TAC
ATG GGT GGG GTG TTG AA-3P) and reverse primer (5P-AAG
AGA GGC ATC CTC ACC CT-3P) for rat L actin.
2.6. Cell extraction, immunoprecipitation and sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
Cells were lysed in lysis bu¡er (30 mM Tris, pH 7.5, 150 mM NaCl,
1 mM phenylmethylsulfonyl £uoride, 1 mM Na3VO4, 1% Nonidet P-
40, 10% glycerol) on ice for 15 min, vortexed and spun at 16 000 rpm
at 4‡C for 10 min. The supernatants were incubated with antibodies
against STAT3 or JAKs (Upstate Biotechnology) at 4‡C for 2 h and
then incubated with protein A agarose beads at 4‡C for another 2 h.
Immunoprecipitated complexes were then washed three times with
lysis bu¡er and dissolved in Laemmli running bu¡er. Samples were
boiled for 4 min and subjected to SDS-PAGE.
2.7. Western blots
After electrophoresis, proteins were transferred onto nitrocellulose
membranes and blocked by incubation for 2 h at room temperature
with 5% milk in TBS plus 0.05% Tween (TBST) when blotted with
anti-phosphotyrosine antibody (4G10, Upstate Biotechnology) or
blocked by incubation with 5% defatted milk in TBST when blotted
with anti-STATs or anti-JAKs. The 4G10 antibody was used at a
1:4000 dilution for overnight incubations at 4‡C, whereas anti-STATs
or anti-JAKs were used at a 1:2500 dilution for 2 h at room temper-
ature. Membranes were washed with TBST and incubated with a
1:4000 dilution of horseradish peroxidase-conjugated secondary anti-
bodies for 45 min. Detection was by the Enhanced Chemilumines-
cence kit (Amersham).
2.8. In vivo labelling of cells with [32P]phosphate
Hepatocytes (2^3U107 cells/ml) were incubated for 1 h in a phos-
phate-free bu¡er (118 mM NaCl, 4.75 mM KCl, 1.2 mM MgCl2, 0.26
mM CaCl2, 25 mM NaHCO3) with V0.5^1 mCi/ml carrier-free
[32P]phosphate in the absence or presence of 0.1 M ethanol for 1 h.
The cells were then stimulated with 20 ng/ml IL-6 for 5 min, followed
by washing twice with phosphate-bu¡ered saline (PBS) containing
1 mM Na3VO4. The cell pellets were lysed and immunoprecipitated
with JAK2 antibody, the proteins fractionated by SDS-PAGE and
analyzed by phosphorimaging.
2.9. Autophosphorylation
Cells were washed twice with PBS containing 1 mM Na3VO4 and
lysed in 0.5 ml of lysis bu¡er. Immunoprecipitated complexes were
washed twice with lysis bu¡er and once with kinase bu¡er (50 mM
Tris, pH 7.4, 5 mM MgCl2, 10 mM MnCl2, 0.1 mM Na3VO4). Pellets
were resuspended in 50 Wl of kinase bu¡er containing 5 WCi of
[Q-32P]ATP and incubated at 30‡C for 10 min. Beads were washed
twice with 500 Wl stop bu¡er (50 mM Tris, pH 7.4, 150 mM NaCl,
10 mM EDTA) and then boiled in SDS sample bu¡er containing 2.5%
2-mercaptoethanol for 5 min. The solubilized proteins were resolved
by SDS-PAGE and quanti¢ed by phosphorimaging.
3. Results
3.1. Ethanol rapidly inhibits IL-6-induced STAT3 activation
and IL-6-induced C/EBPK and C/EBPL mRNA expression
As shown in Fig. 1A, exposure of freshly isolated hepato-
cytes to 20 ng/ml IL-6 for 30 min activates STAT3 as indi-
cated by STAT3 binding to its speci¢c m67 oligonucleotide
probe (lane 1 versus 2). Furthermore, this activation was
dose-dependently inhibited by a 30 min pretreatment with
ethanol, with inhibition already evident at 10 mM and com-
plete at 100 mM ethanol. To determine the rate of onset of
the inhibitory e¡ect of ethanol, cells were exposed to 100 mM
ethanol for various time periods before (B) or after IL-6 stim-
ulation (C). Complete inhibition of STAT3 activation was
evident already after a 2 min pre-incubation with ethanol
and even a 1 min pretreatment caused 90% inhibition (Fig.
1B). Ethanol was also e¡ective when added within 1^3 min
Fig. 1. Ethanol inhibits IL-6-induced STAT3 activation and C/EBP
mRNA expression. (A) Freshly isolated hepatocytes were incubated
with various concentrations of ethanol for 30 min, followed by stim-
ulation with 20 ng/ml of IL-6 for 30 min. Whole cell extracts were
prepared and DMSA was performed using the m67 probe, as de-
scribed under Section 2. (B) Freshly isolated hepatocytes were
treated with 100 mM ethanol for 1^30 min (lanes 3^6), followed by
stimulation with 20 ng/ml of IL-6 for 30 min. DMSA was per-
formed using the m67 probe. (C) 100 mM ethanol was added at
various time points following 20 ng/ml of IL-6 stimulation (lanes 2^
6). After IL-6 stimulation for 30 min, DMSA was performed using
the m67 probe. (D and E) Freshly isolated hepatocytes were treated
with 100 mM ethanol for 30 min and then stimulated with IL-6 for
1 h. The total RNA was isolated and used for RT-PCR (D) or
Northern blotting (E) to determine C/EBPK and L mRNA expres-
sion, as described under Section 2. An autoradiogram representative
of three independent experiments is shown in each panel.
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following IL-6 treatment, causing approximately 60% inhibi-
tion of IL-6-induced STAT3 activation (Fig. 1C, lanes 2^4).
These data indicate that ethanol inhibition of IL-6-induced
STAT3 activation is rapid.
Next, we examined whether ethanol was able to inhibit IL-
6-induced C/EBP gene expression. Freshly isolated hepato-
cytes were treated with 100 mM ethanol for 30 min, then
stimulated with 20 ng/ml of IL-6 for 1 h. The total RNA
was isolated and used for RT-PCR (Fig. 1D) or Northern
analysis (Fig. 1E). It can be seen that IL-6 treatment signi¢-
cantly increased C/EBPK and C/EBPL mRNA expression
(lane 2 in Fig. 1D and E and these e¡ects were inhibited by
pre-incubation with 100 mM ethanol for 30 min (lane 3 in
Fig. 1D and E). It is also evident that ethanol treatment alone
did not a¡ect the basal C/EBPK and L mRNA expression
(lane 4 in Fig. 1D and E).
3.2. Ethanol inhibits IL-6-induced STAT3 tyrosine and serine
phosphorylation
Rapid inhibition of IL-6-induced STAT3 activation by
ethanol could either be due to inhibition of STAT3 translo-
cation or inhibition of STAT3 tyrosine phosphorylation. To
examine the latter possibility, Western analyses were per-
formed by using an anti-phosphotyrosine antibody (Fig. 2A,
upper panel) or an anti-phospho-STAT3 (Tyr705) antibody
(Fig. 2B, upper panel). It could be demonstrated by using
either antibody that IL-6 induced a signi¢cant STAT3 tyro-
sine phosphorylation (lanes 2) and pretreatment of hepato-
cytes with 100 mM ethanol for 30 min abolished this activa-
tion (lanes 3). It is also evident that ethanol alone did not
a¡ect the basal STAT3 tyrosine phosphorylation (lane 4). As
illustrated in the bottom panels of Fig. 2A and B, the same
ethanol treatment did not signi¢cantly a¡ect the cellular level
of the STAT3 protein.
It has been reported that IL-6-induced serine phosphoryla-
tion is also critical for STAT3-promoter complexes [22,23].
Therefore, we wondered whether acute ethanol treatment
also a¡ects IL-6-induced serine phosphorylation. As shown
in Fig. 2C, IL-6 treatment rapidly activates STAT3 serine
phosphorylation (lanes 1^5), the peak e¡ect occurring at 30
min and declining towards control levels after longer (120
min) exposures to IL-6. Pretreatment with 0.1 M ethanol
for 30 min completely abolishes IL-6-induced serine phos-
phorylation (lanes 6^10). Ethanol alone does not a¡ect the
basal STAT3 serine phosphorylation (data not shown). The
bottom panel in Fig. 2C indicated that the same ethanol treat-
ment did not signi¢cantly a¡ect the cellular level of the
STAT3 protein. Taken together, these data suggest that etha-
Fig. 2. Ethanol inhibits IL-6-induced STAT3 tyrosine and serine
phosphorylation. (A) Freshly isolated rat hepatocytes were incu-
bated with 100 mM ethanol or bu¡er for 30 min, then stimulated
with 20 ng/ml of IL-6 for 30 min. The cell lysates were immunopre-
cipitated (IP) with an anti-STAT3 antibody, resolved by SDS-
PAGE and blotted with anti-phosphotyrosine antibody (top panel).
(B and C) Freshly isolated rat hepatocytes were incubated with 100
mM ethanol or bu¡er for 30 min, then stimulated with 20 ng/ml of
IL-6 for 30 min. Cell lysates were resolved by SDS-PAGE and blot-
ted with an anti-phospho-STAT3 (Tyr705) antibody (top panel of B)
or an anti-phospho-STAT3 (Ser727) antibody (top panel of C). In
A^C, the same blot in each top panel was stripped and re-probed
with anti-STAT3 antibody (bottom panel). An autoradiogram repre-
sentative of three independent experiments is shown in each panel.
Fig. 3. E¡ects of acute ethanol on IL-6-induced JAK2 phosphoryla-
tion. (A and B) Freshly isolated rat hepatocytes were pretreated
with 100 mM ethanol for 30 min and then stimulated with 20 ng/ml
of IL-6 for 5 min. Cell extracts were immunoprecipitated (IP) with
JAK2 antibody. The immunoprecipitated JAK2 proteins were sub-
jected to Western blotting using anti-phosphotyrosine antibody (A)
or in vitro autophosphorylation assays (B), as described in Section
2. (C) Cell extracts from freshly isolated rat hepatocytes following
stimulation with 20 ng/ml of IL-6 for 5 min were immunoprecipi-
tated with anti-JAK2 antibody. The immunoprecipitated JAK2 pro-
teins were incubated with or without 100 mM ethanol for 30 min
and then subjected to in vitro autophosphorylation assays. (D)
Freshly isolated hepatocytes were labelled with [32P]phosphate in the
absence or presence of 100 mM ethanol and then stimulated with
IL-6 for 5 min. The labelled phosphorylated JAK2 proteins were
immunoprecipitated with anti-JAK2 antibody and fractionated by
SDS-PAGE. The autoradiograms shown are representatives of three
independent experiments. The radioactivities on the blots were
quanti¢ed by phosphorimaging. Values shown are means þ S.E.M.
from three independent experiments, expressed as fold changes over
control. No signi¢cant di¡erence from the IL-6-stimulated control is
indicated by ampersands; i.e., p denotes Ps 0.05.
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nol inhibition of IL-6-induced STAT3 activation is due to
attenuation of STAT3 tyrosine and serine phosphorylation.
3.3. Acute ethanol does not inhibit IL-6-induced JAK2
phosphorylation in vivo or in vitro
To test whether IL-6-induced STAT3 tyrosine phospho-
rylation was inhibited by ethanol at an upstream site, JAK2
phosphorylation was analyzed by Western blotting, an in vi-
tro kinase assay and in vivo cell labelling. Western analysis
using an anti-phosphotyrosine antibody indicated that IL-6
induced the tyrosine phosphorylation of JAK2 (Fig. 3A,
lane 2) and ethanol treatment did not inhibit this phosphor-
ylation (lane 3). The bottom panel in Fig. 3A illustrates that
similar amounts of protein were loaded in each lane. As illus-
trated in Fig. 3B, IL-6 treatment signi¢cantly induced the in
vitro autophosphorylation of JAK2 (lane 2) and this e¡ect
was only slightly inhibited in extracts prepared from hepato-
cytes treated with 100 mM ethanol (lane 3). Ethanol alone did
not a¡ect the basal JAK2 activity (data not shown). In this
experiment, as well as three replicate experiments with similar
results, ethanol did not signi¢cantly inhibit IL-6-induced
JAK2 phosphorylation.
It has been reported that ethanol can directly inhibit IGF-1
receptor autophosphorylation in vitro [24]. To test whether
ethanol may also directly a¡ect JAK2 autophosphorylation
in vitro, freshly isolated rat hepatocytes were stimulated
with 20 ng/ml of IL-6 for 5 min, cell extracts were then pre-
pared and immunoprecipitated with JAK2 antibody. Immu-
noprecipitated JAK2 proteins were incubated with or without
100 mM ethanol for 30 min and then subjected to in vitro
autophosphorylation assays. As shown in Fig. 3C, ethanol did
not signi¢cantly a¡ect JAK2 autophosphorylation in vitro. In
vitro treatment with ethanol alone did not a¡ect the basal
JAK2 autophosphorylation (data not shown).
Finally, the results of in vivo labelling experiments with
[32P]phosphate have also demonstrated that 100 mM ethanol
treatment does not signi¢cantly inhibit IL-6-induced JAK2
phosphorylation. In this experiment, hepatocytes were incu-
bated with [32P]phosphate in the absence or presence of 100
mM ethanol and then stimulated with IL-6 for 5 min. The
labelled phosphorylated JAK2 proteins were immunoprecipi-
tated with anti-JAK2 antibody. As shown in Fig. 3D, IL-6
treatment signi¢cantly stimulated JAK2 phosphorylation in
vivo (lane 2) and 100 mM ethanol treatment did not a¡ect
this activation (lane 3).
3.4. Acute ethanol treatment potentiates IL-6-induced JAK1
phosphorylation in vivo and in vitro
Next, we examined the e¡ects of ethanol on IL-6-induced
JAK1 phosphorylation. As shown in Fig. 4A, IL-6 stimula-
tion slightly activated JAK1 phosphorylation (lane 2). Sur-
prisingly, pretreatment with 100 mM ethanol for 30 min sig-
ni¢cantly potentiated this activation (lane 3). In a total of four
replicate experiments, ethanol potentiated the IL-6-induced
JAK1 phosphorylation by 2.2 þ 0.1-fold, as quanti¢ed with a
phosphorimager (Fig. 4A). To test whether ethanol potentia-
tion of IL-6-induced JAK1 phosphorylation is due to a direct
e¡ect of ethanol, the IL-6-activated JAK1 immunoprecipi-
tated complex was incubated without or with 100 mM ethanol
for 30 min and then subjected to in vitro autophosphoryla-
tion. As shown in Fig. 4B, ethanol signi¢cantly potentiated
JAK2 in vitro autophosphorylation by 2.1 þ 0.2-fold. Treat-
ment with ethanol alone did not a¡ect the basal JAK1 auto-
phosphorylation (data not shown). These ¢ndings suggest that
Fig. 4. E¡ects of acute ethanol on IL-6-induced JAK1 phosphoryla-
tion. (A) Freshly isolated rat hepatocytes were pretreated with 100
mM ethanol for 30 min and then stimulated with 20 ng/ml of IL-6
for 5 min. Cell extracts were immunoprecipitated (IP) with JAK1
antibody. The immunoprecipitated JAK1 proteins were subjected to
in vitro autophosphorylation assays. (B) Cell extracts from freshly
isolated rat hepatocytes following stimulation with 20 ng/ml of IL-6
for 5 min were immunoprecipitated with anti-JAK1 antibody. The
immunoprecipitated JAK1 proteins were incubated without or with
100 mM ethanol for 30 min and then subjected to in vitro auto-
phosphorylation assays. The autoradiograms shown are representa-
tives of three independent experiments. The radioactivities on the
blots were quanti¢ed by phosphorimaging. Values shown are means
þ S.E.M. from three independent experiments, expressed as fold
changes over control. Signi¢cant di¡erence from the IL-6-stimulated
control is indicated by asterisks; i.e., * denotes P6 0.01.
Fig. 5. E¡ects of acute ethanol on IL-6-induced Tyk2 phosphoryla-
tion. (A) Freshly isolated rat hepatocytes were pretreated with 100
mM ethanol for 30 min and then stimulated with 20 ng/ml of IL-6
for 5 min. Cell extracts were immunoprecipitated (IP) with Tyk2
antibody. The immunoprecipitated Tyk2 proteins were subjected to
in vitro autophosphorylation assays. (B) Cell extracts from freshly
isolated rat hepatocytes following stimulation with 20 ng/ml of IL-6
for 5 min were immunoprecipitated with Tyk2 antibody. The immu-
noprecipitated Tyk2 proteins were incubated without or with 100
mM ethanol for 30 min and then subjected to in vitro autophos-
phorylation assays. The autoradiograms shown are representatives
of three independent experiments. The radioactivities on the blots
were quanti¢ed by phosphorimaging. Values shown are means
þ S.E.M. from three independent experiments, expressed as fold
changes over control. No signi¢cant di¡erence from IL-6-stimulated
control is indicated by ampersands; i.e., Ps 0.05.
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ethanol potentiation of IL-6-induced JAK1 phosphorylation
is due to a direct e¡ect of ethanol on IL-6-activated JAK1.
3.5. Acute ethanol does not a¡ect IL-6-induced Tyk2
phosphorylation in vivo or in vitro
E¡ects of ethanol on IL-6-induced Tyk2 phosphorylation in
vivo and in vitro were also examined. As shown in Fig. 5A,
IL-6 signi¢cantly activated Tyk2 phosphorylation and treat-
ment of hepatocytes with 100 mM ethanol slightly but not
signi¢cantly increased this activation. In Fig. 5B, the Tyk2-
immunoprecipitated complex was incubated with or without
100 mM ethanol for 30 min and then subjected to in vitro
autophosphorylation. Ethanol only slightly increased the in
vitro autophosphorylation of Tyk2. This suggests that ethanol
does not signi¢cantly a¡ect IL-6-induced Tyk2 phosphoryla-
tion.
3.6. Tyrosine phosphatases and the ubiquitin-proteasome
pathway are not involved in ethanol inhibition of
IL-6-induced STAT3 activation
The ethanol inhibition of STAT3 tyrosine phosphorylation
could be due to inactivation of kinases responsible for tyro-
sine phosphorylation of STAT3 or, alternatively, due to acti-
vation of a protein tyrosine phosphatase (PTPase) which de-
phosphorylates STAT3. To examine the latter possibility,
hepatocytes were pretreated with the non-selective tyrosine
phosphatase inhibitor sodium orthovanadate for 30 min, fol-
lowed by IL-6 treatment for 30 min. Cell lysates were then
subjected to a gel mobility shift assay to quantify STAT3
binding. As shown in Fig. 6, 0.5 or 1 mM sodium vanadate
slightly enhanced IL-6-induced STAT3 activation (lanes 5 and
7) but did not prevent the ethanol inhibition of IL-6-induced
STAT3 activation (lanes 6 and 8). This suggests that tyrosine
phosphatases are not involved in ethanol inhibition of IL-6-
induced STAT3 activation.
The ubiquitin-proteasome pathway has been implicated in
the downregulation of activated STATs [25^27]. We wondered
whether this pathway was also involved in ethanol-mediated
inhibition of IL-6 activation of STAT3. As shown in Fig. 6,
pretreatment of hepatocytes with the proteasome inhibitors,
MG132 or lactacystin, did not signi¢cantly antagonize etha-
nol-mediated inhibition of IL-6 activation of STAT3, suggest-
ing that the ubiquitin-proteasome pathway was not involved
in ethanol inhibition of IL-6-induced STAT3 activation.
4. Discussion
In the present paper, we demonstrate that in freshly isolated
rat hepatocytes, biologically relevant concentrations of etha-
nol rapidly and dose-dependently inhibit IL-6-induced activa-
tion of STAT3, as well as the expression of the downstream
target genes C/EBPK and C/EBPL. The results further indicate
that this action of ethanol is not due to inhibition of up-
stream-located JAK1, JAK2 and Tyk2 kinases or activation
of a tyrosine phosphatase, but probably involves direct inhib-
ition of STAT3 tyrosine and serine phosphorylation. Ethanol
inhibition of STAT3 phosphorylation develops rapidly and it
is also evident when ethanol exposure follows the stimulation
of IL-6. These observations also support the notion that etha-
nol directly interferes with STAT3 phosphorylation. However,
the exact cellular mechanism by which ethanol inhibits
STAT3 tyrosine phosphorylation remains unclear.
PTPases [10^14] and the ubiquitin-proteasome pathway
[25^27] have been implicated in the inhibition of JAK-STAT
signaling pathways. The ¢nding that the tyrosine phosphatase
inhibitor sodium vanadate and the proteasome inhibitors
MG132 and lactacystin do not antagonize the inhibitory ef-
fects of ethanol on STAT3 activation suggests that PTPases
and the ubiquitin-proteasome pathway are not involved. On
the other hand, our preliminary data showed that pretreat-
ment of the cells with GF 109203X, a highly selective protein
kinase C (PKC) inhibitor, largely prevents ethanol inhibition
of IL-6-induced STAT3 activation (unpublished observa-
tions), suggesting that PKC is involved. It has been shown
that acute exposure of hepatocytes to ethanol induces a rapid
but transient activation of phosphoinositide-speci¢c phospho-
lipase C and a consequent rise in cytosolic Ca2 and diacyl-
glycerol, which can further activate PKC [28]. However, the
mechanism by which PKC inhibits IL-6-induced STAT3 acti-
vation is not clear. It has been proposed that the PKA-de-
pendent inhibition of INFK/L-induced JAK-STAT activation
is mediated through an interaction of PKA with the cytoplas-
mic domain of the K chain of the INFK/L receptor [29]. By
analogy, it is possible that the ethanol-activated PKC interacts
directly with the STAT3 protein to inhibit its activation. In-
terestingly, acute ethanol treatment also signi¢cantly inhibits
INFQ-induced STAT1 activation and growth hormone-in-
duced STAT5 activation (unpublished observations), suggest-
ing that ethanol may interfere with the phosphorylation of
STAT proteins in general and its molecular target may be
conserved domains of STAT proteins. It is known that all
STATs contain a highly conserved SH2 domain, which is
critical for the recruitment of STATs to activated receptor
complexes and for their interaction with JAKs [1^3]. There-
fore, the general inhibitory e¡ect of ethanol on STATs may be
due to modulation of SH2 domains by ethanol-activated
PKC. Indeed, it has been reported that several kinases con-
taining SH2 domains can be a¡ected by ethanol [30^34].
It has been reported that acute ethanol exposure directly
inhibits IGF-1 receptor autophosphorylation in vitro [24] and
chronic ethanol ingestion was found to impair EGF receptor
autophosphorylation [35]. However, in the present experi-
Fig. 6. Tyrosine phosphatases and the ubiquitin-proteasome path-
way are not involved in ethanol inhibition of IL-6-induced STAT3
activation. Freshly isolated rat hepatocytes were pretreated with
bu¡er, sodium vanadate (A) or proteasome inhibitors (50 WM
MG135, 50 WM lactacystin) (B) for 30 min, followed by incubation
with or without 100 mM ethanol for 30 min and then stimulated
with 20 ng/ml of IL-6 for 30 min. DMSA was performed using the
m67 probe. An autoradiogram representative of three independent
experiments is shown in each panel.
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ments, acute ethanol exposure did not inhibit JAK1, JAK2
and Tyk2 autophosphorylation, which eliminates these kin-
ases as the possible cellular targets through which ethanol
inhibits STAT3 phosphorylation. Instead, ethanol was found
to markedly potentiate IL-6-induced JAK1 autophosphoryla-
tion. Ethanol alone did not stimulate JAK autophosphoryla-
tion but potentiated IL-6-induced JAK1 autophosphoryla-
tion. This suggests that ethanol acts on the JAK1 protein
only once it has been phosphorylated and it probably modu-
lates the phosphotyrosine residues, ATP binding domains or
the conformation of the activated JAK1 protein. Regardless
of the exact target site(s) of ethanol on the activated JAK1
protein, this e¡ect is clearly insu⁄cient to overcome the ap-
parent inhibition of the JAK-STAT signaling pathway at a
site downstream of JAK1.
IL-6 exempli¢es a typical pleiotropic cytokine that modu-
lates the transcription of many genes, including members of
the C/EBP family of transcription factors [36]. It has been
reported that IL-6 directly stimulates C/EBPL gene expression
by acting on STAT binding sites within its promoter region
[37,38]. The e¡ects of IL-6 on C/EBPK gene expression are
less clear, there being only one report on IL-6-induced inhib-
ition of hepatic C/EBPK gene expression in vivo [39] and no
reports on the e¡ect of IL-6 on C/EBPK gene expression in
hepatocytes. The present study clearly demonstrates that IL-6
can directly stimulate C/EBPK gene expression, which sug-
gests that the reported downregulation of C/EBPK gene ex-
pression by in vivo injection of IL-6 is an indirect e¡ect. The
parallel upregulation of C/EBPK and C/EBPL gene expression
by IL-6 is somewhat unexpected in view of the di¡erent and,
in some ways, opposite functions of these two members of the
C/EBP family of transcription factors. Like IL-6, C/EBPL is
believed to play a key role in hepatocyte proliferation. C/
EBPL is upregulated in the regenerating liver [40^42] and liver
development and regeneration are severely compromised in C/
EBPL knockout mice [43]. In contrast, C/EBPK is most highly
expressed in terminally di¡erentiated hepatocytes and inhibits
hepatocyte proliferation [36] and is thought to have a key role
in the control of di¡erentiated liver functions, such as the
regulation of energy homeostasis [44]. The increase in the
expression of both C/EBPK and C/EBPL by IL-6 may serve
to promote a tightly controlled process where hepatocyte pro-
liferation is closely coupled to terminal di¡erentiation to allow
for uninterrupted metabolic functions in the regenerating liv-
er. On the other hand, the demonstrated ability of ethanol to
inhibit the IL-6-induced expression of C/EBPL may be one of
the mechanisms by which ethanol inhibits the regenerative
response in the liver, whereas the concomitant suppression
of IL-6-induced C/EBPK gene expression by ethanol could
contribute to the well-documented disturbances in liver carbo-
hydrate metabolism in chronic drinkers with alcoholic liver
disease [45].
In summary, the present ¢ndings demonstrate that biolog-
ically relevant concentrations of ethanol markedly inhibit IL-
6-induced STAT3 tyrosine and serine phosphorylation and
IL-6-activated C/EBPK and L mRNA expression in freshly
isolated hepatocytes and that STAT3 is likely a direct molec-
ular target of ethanol. The inhibitory e¡ects of ethanol on
STAT proteins may also be involved in other alcohol-associ-
ated disorders, such as anemia, thrombocytopenia, immuno-
suppression, fetal alcohol syndrome, etc., since the STAT pro-
teins have been implicated in a variety of cellular functions in
the hematopoietic, immunologic, neuronal and hepatic system
[1^8]. Therefore, the e¡ects of ethanol on the JAK-STAT
signaling pathways in other cells deserve further scrutiny.
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